ALXO — ALX Oncology Holdings
Median target
$4
calls from the last 12 months
Implied return
+129.9%
median target vs. price
Coverage
4 analysts · 5 calls
updated in the last 12 months
Consensus
3/1/0+3 net
Buy / Hold / Sell
Which analysts are behind ALXO's consensus?
See every current rating, price target and the analysts' track records for ALX Oncology Holdings — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 4 analysts with calls on ALXO updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
ALXO elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-17 | Insiders | Lettmann JasonCHIEF EXECUTIVE OFFICER | Insider sale | 2.2K sh @ $1.93 | $4K |
| 2026-08-17 | Insiders | Wong ShellySVP, FINANCE AND CAO | Insider sale | 573 sh @ $1.93 | $1K |
More: insider activity · executive branch · trending